Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

por Graffeo, R., Rana, H.Q., Conforti, F., Bonanni, B., Cardoso, M.J., Paluch-Shimon, S., Pagani, O., Goldhirsch, A., Partridge, A.H., Lambertini, M., Garber, J.E.
Publicado 2022

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

por Birkbak, N J, Li, Y, Pathania, S, Greene-Colozzi, A, Dreze, M, Bowman-Colin, C, Sztupinszki, Z, Krzystanek, M, Diossy, M, Tung, N, Ryan, P D, Garber, J E, Silver, D P, Iglehart, J D, Wang, Z C, Szuts, D, Szallasi, Z, Richardson, A L
Publicado 2018

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

por Schrader, K A, Masciari, S, Boyd, N, Salamanca, C, Senz, J, Saunders, D N, Yorida, E, Maines-Bandiera, S, Kaurah, P, Tung, N, Robson, M E, Ryan, P D, Olopade, O I, Domchek, S M, Ford, J, Isaacs, C, Brown, P, Balmana, J, Razzak, A R, Miron, P, Coffey, K, Terry, M B, John, E M, Andrulis, I L, Knight, J A, O'Malley, F P, Daly, M, Bender, P, Moore, R, Southey, M C, Hopper, J L, Garber, J E, Huntsman, D G
Publicado 2010